Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morton

Showing results (951-960 of 1,110) with videos related to

Pageof 111
Sort By:
Frontiers in Oncology|June 7, 2014
Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 LevelsAnna M Leung, Agnes Fermin Lee, Junko Ozao-Choy, et al.
Kidney International|June 8, 2023
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceRajnish Mehrotra, Sara N Davison, Ken Farrington, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 26, 2023
Depression and anxiety in caregivers of patients with functional seizuresKonstantinos Tsamakis, Diane L Teagarden, Hannah K Villarreal, et al.
BMJ Open|January 23, 2023
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paperDale Jobson, Benjamin Roffey, Renee Best, et al.
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Kidney International|April 30, 2015
Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality careSara N Davison, Adeera Levin, Alvin H Moss, et al.
American Heart Journal|June 29, 2024
Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trialPrajith Jeyaprakash, Faraz Pathan, Koya Ozawa, et al.
JAMA Dermatology|March 1, 2018
Patient Preferences for Follow-up After Recent Excision of a Localized MelanomaWei-Yin Lim, Rachael L Morton, Robin M Turner, et al.
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Pageof 111

Showing results (951-960 of 1,110) with videos related to

Sort By:
Pageof 111
Frontiers in Oncology|June 7, 2014
Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 LevelsAnna M Leung, Agnes Fermin Lee, Junko Ozao-Choy, et al.
Kidney International|June 8, 2023
Managing the symptom burden associated with maintenance dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceRajnish Mehrotra, Sara N Davison, Ken Farrington, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|June 26, 2023
Depression and anxiety in caregivers of patients with functional seizuresKonstantinos Tsamakis, Diane L Teagarden, Hannah K Villarreal, et al.
BMJ Open|January 23, 2023
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paperDale Jobson, Benjamin Roffey, Renee Best, et al.
Pediatric Blood & Cancer|October 27, 2009
Initial testing (stage 1) of mapatumumab (HGS-ETR1) by the pediatric preclinical testing programMalcolm A Smith, Christopher L Morton, E Anders Kolb, et al.
Pediatric Blood & Cancer|August 27, 2010
Initial testing (stage 1) of the Akt inhibitor GSK690693 by the pediatric preclinical testing programHernan Carol, Christopher L Morton, Richard Gorlick, et al.
Kidney International|April 30, 2015
Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality careSara N Davison, Adeera Levin, Alvin H Moss, et al.
American Heart Journal|June 29, 2024
Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trialPrajith Jeyaprakash, Faraz Pathan, Koya Ozawa, et al.
JAMA Dermatology|March 1, 2018
Patient Preferences for Follow-up After Recent Excision of a Localized MelanomaWei-Yin Lim, Rachael L Morton, Robin M Turner, et al.
Pediatric Blood & Cancer|June 18, 2011
Initial testing (stage 1) of LCL161, a SMAC mimetic, by the Pediatric Preclinical Testing ProgramPeter J Houghton, Min H Kang, C Patrick Reynolds, et al.
Pageof 111